| Name | Cvs Pharmacy #10274 |
|---|---|
| Organization Name | Oklahoma Cvs Pharmacy Llc |
| Location | 1520 W Elk Ave, Duncan, Oklahoma 73533 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (580) 470-8857 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Dr. Stanton Peele's extensive research concludes that there is no evidence that biological or genetic mechanisms have been identified for addictive behavior or that addictive behavior is therefore inherited. The inherited addiction gene theory is widely used by the majority of alcohol and drug rehab programs, but Peele's research reveals that addiction is just too complicated to be contained within a simple inherited gene.
Improving the ability to provide premium patient care during interventional procedures, Toshiba America Medical Systems, Inc. is expanding the availability of Next Generation Advanced Image Processing (AIP) to more systems in the Toshiba InfinixTM-i product line.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The study is aimed at evaluating the safety and tolerability of ALN-TTR02 in healthy volunteers.
The technique, pioneered by the University of Kent, is funded by the Toronto-based company, Ophthalmic Technology Inc (OTI). The University's Applied Optics Group is currently working with university hospitals in New York (USA), Osaka (Japan), Asahikawa (Japan), Amsterdam (Netherlands) and Milan (Italy) to carry out preliminary clinical trials.
› Verified 2 days ago
| NPI Number | 1871935767 |
| Organization Name | OKLAHOMA CVS PHARMACY, L.L.C. |
| Doing Business As | CVS PHARMACY #10274 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1520 W Elk Ave, Duncan, OK 73533 |
| Phone Number | 580-470-8857 |
News Archive
Dr. Stanton Peele's extensive research concludes that there is no evidence that biological or genetic mechanisms have been identified for addictive behavior or that addictive behavior is therefore inherited. The inherited addiction gene theory is widely used by the majority of alcohol and drug rehab programs, but Peele's research reveals that addiction is just too complicated to be contained within a simple inherited gene.
Improving the ability to provide premium patient care during interventional procedures, Toshiba America Medical Systems, Inc. is expanding the availability of Next Generation Advanced Image Processing (AIP) to more systems in the Toshiba InfinixTM-i product line.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The study is aimed at evaluating the safety and tolerability of ALN-TTR02 in healthy volunteers.
The technique, pioneered by the University of Kent, is funded by the Toronto-based company, Ophthalmic Technology Inc (OTI). The University's Applied Optics Group is currently working with university hospitals in New York (USA), Osaka (Japan), Asahikawa (Japan), Amsterdam (Netherlands) and Milan (Italy) to carry out preliminary clinical trials.
› Verified 2 days ago
News Archive
Dr. Stanton Peele's extensive research concludes that there is no evidence that biological or genetic mechanisms have been identified for addictive behavior or that addictive behavior is therefore inherited. The inherited addiction gene theory is widely used by the majority of alcohol and drug rehab programs, but Peele's research reveals that addiction is just too complicated to be contained within a simple inherited gene.
Improving the ability to provide premium patient care during interventional procedures, Toshiba America Medical Systems, Inc. is expanding the availability of Next Generation Advanced Image Processing (AIP) to more systems in the Toshiba InfinixTM-i product line.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The study is aimed at evaluating the safety and tolerability of ALN-TTR02 in healthy volunteers.
The technique, pioneered by the University of Kent, is funded by the Toronto-based company, Ophthalmic Technology Inc (OTI). The University's Applied Optics Group is currently working with university hospitals in New York (USA), Osaka (Japan), Asahikawa (Japan), Amsterdam (Netherlands) and Milan (Italy) to carry out preliminary clinical trials.
› Verified 2 days ago
Cvs Pharmacy #10274 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1520 W Elk Ave, Duncan, Oklahoma 73533 Phone: (580) 470-8857 | |
Walgreens #5142 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1100 N Highway 81, Duncan, Oklahoma 73533 Phone: (580) 252-2375 | |
Walmart Pharmacy 10-1160 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3393 N 81 Hwy, Duncan, Oklahoma 73533 Phone: (580) 252-4888 | |
Baker Express Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3344 N Hwy 81, Duncan, Oklahoma 73533 Phone: (580) 255-3784 | |
R&s Drug Store #3 Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3117 N Highway 81, Duncan, Oklahoma 73533 Phone: (580) 252-0140 |